Abstract 2591: Synthetic optimization of polyisoprenylated cysteinyl amide inhibitors to target cancers with hyperactive G-proteins - KIVIRID

Abstract 2591: Synthetic optimization of polyisoprenylated cysteinyl amide inhibitors to target cancers with hyperactive G-proteins

Authors: Nada Tawfeeq, Yonghao Jin, Nazarius S. Lamango

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-2591

Source: Full article

Abstract

Abstract